PAR paradigm biopharmaceuticals limited..

YIN AND YANG Part 2, page-7

  1. 10,383 Posts.
    lightbulb Created with Sketch. 1414
    They have publicly stated now multiple times they are holding off on doing a deal given it is expected to: (1) maximise shareholder outcomes, (2) have the balance sheet to manage without one and (3) shows an incredible level of confidence in passing phase 3 trials. The recent hires all show the intent to make this a guaranteed blockbuster before they seriously consider a deal. And no you don't have to disclose preliminary or even indicative discussions.

    I note a deal for MPS may be a different matter and is a potential near term wild card IMO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.020(4.55%)
Mkt cap ! $166.9M
Open High Low Value Volume
44.5¢ 44.5¢ 41.5¢ $271.6K 637.8K

Buyers (Bids)

No. Vol. Price($)
2 5960 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 3696 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.